A detailed history of Voya Investment Management LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 58,993 shares of MGNX stock, worth $191,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,993
Previous 21,323 176.66%
Holding current value
$191,137
Previous $90,000 115.56%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.0 - $5.55 $113,010 - $209,068
37,670 Added 176.66%
58,993 $194,000
Q2 2024

Aug 14, 2024

BUY
$3.31 - $18.51 $3,876 - $21,675
1,171 Added 5.81%
21,323 $90,000
Q1 2024

May 15, 2024

SELL
$9.77 - $21.47 $188,267 - $413,726
-19,270 Reduced 48.88%
20,152 $296,000
Q4 2023

Feb 14, 2024

SELL
$4.48 - $10.11 $56,080 - $126,556
-12,518 Reduced 24.1%
39,422 $379,000
Q3 2023

Nov 14, 2023

BUY
$4.48 - $6.19 $20,616 - $28,486
4,602 Added 9.72%
51,940 $242,000
Q2 2023

Aug 14, 2023

BUY
$4.62 - $7.54 $7,119 - $11,619
1,541 Added 3.36%
47,338 $253,000
Q1 2023

May 15, 2023

SELL
$4.82 - $7.24 $43,148 - $64,812
-8,952 Reduced 16.35%
45,797 $328,000
Q4 2022

Feb 14, 2023

SELL
$3.34 - $6.98 $44,872 - $93,776
-13,435 Reduced 19.7%
54,749 $367,000
Q3 2022

Mar 03, 2023

BUY
$3.01 - $5.22 $40,439 - $70,130
13,435 Added 24.54%
68,184 $207,000
Q3 2022

Nov 14, 2022

SELL
$3.01 - $5.22 $86,672 - $150,309
-28,795 Reduced 29.69%
68,184 $236,000
Q2 2022

Aug 15, 2022

BUY
$2.25 - $9.99 $131,094 - $582,057
58,264 Added 150.49%
96,979 $286,000
Q1 2022

May 16, 2022

BUY
$8.12 - $16.9 $55,589 - $115,697
6,846 Added 21.48%
38,715 $341,000
Q4 2021

Feb 14, 2022

BUY
$15.91 - $21.88 $8,845 - $12,165
556 Added 1.78%
31,869 $511,000
Q3 2021

Nov 15, 2021

BUY
$19.74 - $28.7 $4,737 - $6,888
240 Added 0.77%
31,313 $656,000
Q2 2021

Aug 16, 2021

BUY
$20.49 - $35.63 $56,204 - $97,733
2,743 Added 9.68%
31,073 $834,000
Q1 2021

May 17, 2021

SELL
$18.99 - $33.2 $21,857 - $38,213
-1,151 Reduced 3.9%
28,330 $902,000
Q4 2020

Feb 16, 2021

BUY
$19.41 - $26.0 $104,949 - $140,582
5,407 Added 22.46%
29,481 $674,000
Q3 2020

Nov 16, 2020

BUY
$24.69 - $31.6 $184,335 - $235,925
7,466 Added 44.95%
24,074 $606,000
Q2 2020

Aug 14, 2020

SELL
$5.2 - $29.12 $30,893 - $173,001
-5,941 Reduced 26.35%
16,608 $464,000
Q4 2019

Feb 14, 2020

BUY
$7.95 - $12.27 $37,301 - $57,570
4,692 Added 26.28%
22,549 $245,000
Q2 2019

Aug 14, 2019

BUY
$14.51 - $19.71 $21,576 - $29,308
1,487 Added 9.08%
17,857 $303,000
Q1 2019

May 15, 2019

SELL
$11.11 - $25.6 $1.87 Million - $4.31 Million
-168,323 Reduced 91.14%
16,370 $294,000
Q4 2018

Feb 14, 2019

SELL
$11.75 - $21.42 $8.56 Million - $15.6 Million
-728,285 Reduced 79.77%
184,693 $2.35 Million
Q3 2018

Nov 14, 2018

BUY
$19.26 - $23.46 $139,172 - $169,521
7,226 Added 0.8%
912,978 $19.6 Million
Q2 2018

Aug 14, 2018

BUY
$19.78 - $24.67 $10.7 Million - $13.4 Million
542,319 Added 149.22%
905,752 $18.7 Million
Q1 2018

May 15, 2018

SELL
$18.89 - $32.46 $4.04 Million - $6.94 Million
-213,748 Reduced 37.03%
363,433 $9.14 Million
Q4 2017

Feb 14, 2018

BUY
$16.19 - $20.3 $1.2 Million - $1.5 Million
74,036 Added 14.71%
577,181 $11 Million
Q3 2017

Nov 14, 2017

BUY
$15.52 - $18.94 $7.81 Million - $9.53 Million
503,145
503,145 $9.3 Million

Others Institutions Holding MGNX

About MACROGENICS INC


  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $199M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.